jgrabar
3 년 전
On 8/24/21, a class action survived a motion to dismiss and that action is now in settlement mediation. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Corcept had improperly paid doctors to promote its drug Korlym; (2) Corcept aggressively promoted Korlym for off-label uses; (3) Corcept’s sole specialty pharmacy was a related party; (4) Corcept artificially inflated its revenue and sales using illicit sales practices through a related party; (5) such practices were reasonably likely to lead to regulatory scrutiny; and (6) as a result, defendants’ positive statements about Corcept’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
Longer term holders may be able to seek corporate governance reforms and an incentive award where appropriate.
to learn more, contact jgrabar@grabarlaw.com
stocktrademan
9 년 전
$CORT recent news/filings
bullish 5.19
moving average support
## source: finance.yahoo.com
Wed, 02 Dec 2015 13:00:01 GMT ~ BioLineRx (BLRX) Worth Watching: Stock Rises 11.3%
read full: http://finance.yahoo.com/news/biolinerx-blrx-worth-watching-stock-130001295.html
*********************************************************
Tue, 01 Dec 2015 13:00:01 GMT ~ Affimed (AFMD) Shows Strength: Stock Moves 6.7% Higher
read full: http://finance.yahoo.com/news/affimed-afmd-shows-strength-stock-130001649.html
*********************************************************
Mon, 23 Nov 2015 21:05:09 GMT ~ SurModics Buys Balloon Catheter Maker Creagh Medical
read full: http://finance.yahoo.com/news/surmodics-buys-balloon-catheter-maker-210509609.html
*********************************************************
Mon, 23 Nov 2015 18:38:06 GMT ~ Pharma Industry Outlook: Pricing Pressure and M&As in Focus
read full: http://finance.yahoo.com/news/pharma-industry-outlook-pricing-pressure-183806341.html
*********************************************************
Fri, 20 Nov 2015 13:15:01 GMT ~ Merus Labs International (MSLI) Jumps: Stock Rises 6.4%
read full: http://finance.yahoo.com/news/merus-labs-international-msli-jumps-131501012.html
*********************************************************
$CORT charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CORT company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CORT/company-info
Ticker: $CORT
OTC Market Place: Not Available
CIK code: 0001088856
Company name: Corcept Therapeutics, Inc.
Incorporated In: DE, USA
$CORT share structure
## source: otcmarkets.com
Market Value: $583,039,022 a/o Dec 02, 2015
Shares Outstanding: 108,775,937 a/o Oct 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$CORT extra dd links
Company name: Corcept Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CORT/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CORT/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CORT+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CORT+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CORT+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/news - http://finance.yahoo.com/q/h?s=CORT+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CORT/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CORT/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CORT/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CORT/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CORT+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CORT
DTCC (dtcc.com): http://search2.dtcc.com/?q=Corcept+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Corcept+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Corcept+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CORT/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CORT
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CORT/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CORT/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CORT/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001088856&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CORT/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CORT/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CORT&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CORT
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CORT+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CORT+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CORT
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CORT
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CORT+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CORT/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CORT+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CORT.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CORT
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CORT/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CORT/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CORT/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CORT
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CORT
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CORT:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CORT
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CORT
$CORT DD Notes ~ http://www.ddnotesmaker.com/CORT
stocktrademan
9 년 전
$CORT recent news/filings
bullish
## source: finance.yahoo.com
Fri, 22 May 2015 08:38:46 GMT ~ Cortendo Announces Notice of Annual General Meeting
[at noodls] - Cortendo Announces Notice of Annual General Meeting
read full: http://www.noodls.com/view/6779E5F5E925D344BA1E386121DF8944DBB662A3
*********************************************************
Thu, 21 May 2015 20:14:00 GMT ~ CORCEPT THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
read full: http://biz.yahoo.com/e/150521/cort8-k.html
*********************************************************
Tue, 19 May 2015 06:51:35 GMT ~ Notification of Trade
[at noodls] - Notification of Trade
read full: http://www.noodls.com/view/DCA2A0BD9465F624CB88039645F749CB43BA642F
*********************************************************
Fri, 15 May 2015 19:25:07 GMT ~ Corcept Therapeutics' Korlym Positive in Breast Cancer Study - Analyst Blog
read full: http://finance.yahoo.com/news/corcept-therapeutics-korlym-positive-breast-192507149.html
*********************************************************
Fri, 15 May 2015 17:04:14 GMT ~ CORCEPT THERAPEUTICS INC Financials
read full: http://finance.yahoo.com/q/is?s=cort
*********************************************************
$CORT charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CORT company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CORT/company-info
Ticker: $CORT
OTC Market Place: Not Available
CIK code: 0001088856
Company name: Corcept Therapeutics, Inc.
Incorporated In: DE, USA
$CORT share structure
## source: otcmarkets.com
Market Value: $634,674,364 a/o May 28, 2015
Shares Outstanding: 107,754,561 a/o May 01, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$CORT extra dd links
Company name: Corcept Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CORT/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CORT/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CORT+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CORT+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CORT+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/news - http://finance.yahoo.com/q/h?s=CORT+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CORT/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CORT/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CORT/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CORT/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CORT+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CORT
DTCC (dtcc.com): http://search2.dtcc.com/?q=Corcept+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Corcept+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Corcept+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CORT/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CORT
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CORT/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CORT/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CORT/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001088856&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CORT/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CORT/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CORT&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CORT
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CORT+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CORT+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CORT
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CORT
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CORT+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CORT/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CORT+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CORT.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CORT
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CORT/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CORT/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CORT/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CORT
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CORT
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CORT:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CORT
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CORT
$CORT DD Notes ~ http://www.ddnotesmaker.com/CORT
Thurly
10 년 전
Corcept Therapeutics Announces Poster Presentations on Mifepristone
for the Treatment of Patients with Cushing’s Syndrome
at the 27th Annual American Association of Clinical Endocrinologists
Press Release delivered via email
MENLO PARK, Calif. (May 14, 2015) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, oncologic and psychiatric disorders, today announced that four posters about mifepristone will be presented at the 24th annual American Association of Clinical Endocrinologists (AACE) being held at the Music City Convention Center in Nashville, TN from May 13 – 17, 2015.
“We are pleased that physicians have taken a strong interest in mifepristone and its potential to treat patients with Cushing’s syndrome,” said Joseph K. Belanoff, M.D., Corcept’s Chief Executive Officer.
In addition to presentation of the four abstracts described below, AACE attendees will have the opportunity to attend a “Product Theatre” talk by Ty Carroll, M.D., whose topic will be “Not-So-Subclinical Cushing’s Syndrome.” Corcept is a sponsor of Dr. Carroll’s presentation.
Friday, May 15, 2015
Poster #131: “Resistant metabolic abnormalities prompting Cushing’s syndrome work-up and treatment with mifepristone”
Douglas Beatty, M.D., Rachel Bunta, Dat Nguyen, PharmD
Poster # 840: “Mifepristone re-established glycemic control in a Cushing’s syndrome patient that relapsed after a 21 month interruption”
Todd Frieze, M.D., James Smith, Ph. D.
Product Theater: “Not-So-Subclinical Cushing’s Syndrome”
Ty Carroll, M.D.
Saturday, May 16, 2015
Late-Breaking Poster: “Use of mifepristone in an ectopic Cushing’s syndrome patient pending tumor localization”
Adeela Ansari, M.D., Precious Lim, Ph.D., Dat Nguyen, PharmD
Late-Breaking Poster: “Improved response to octreotide LAR for ectopic Cushing’s syndrome during mifepristone therapy: A case study”
Andreas Moraitis, M.D., Richard Auchus, M.D.
Thurly
10 년 전
CORCEPT THERAPEUTICS’ MIFEPRISTONE COMBINED WITH ERIBULIN TO IMPROVE ANTITUMOR ACTIVITY IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER
http://www.marketwatch.com/story/corcept-therapeutics-mifepristone-combined-with-eribulin-to-improve-antitumor-activity-in-patients-with-triple-negative-breast-cancer-2015-05-13
Patients with metastatic breast cancer (five with triple-negative breast cancer) were treated with mifepristone and eribulin at three different dose levels. The study consisted of seven patients with GR-positive tumors, three patients with GR-negative tumors and three patients with unknown GR status. Two partial responses have been observed, both in patients with GR-positive cancer.
The study title shows it includes patients who do not have triple negative breast cancer:
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT02014337?term=Triple+Negative+Breast+Cancer+mifepristone&rank=1
In fact, the study accepts Breast Cancer, Ovarian Epithelial Cancer Recurrent, Sarcoma, Non-small Cell Lung Cancer, Carcinoma, Transitional Cell, Prostate Cancer, Prostatic Neoplasms
From the title of the press release, one would assume that of the two partial responses, at least one of them was in TNBC, but it's not entirely clear from the text.
What's clear is that both patients had GR-positive tumors and advanced disease.
From the press release: An additional 20 patients with GR-positive metastatic TNBC will be enrolled into the study’s efficacy phase.
Thurly
10 년 전
On April 28, 2015 Bloomberg reported Corcept withdrew Korlym's marketing application in the EU.
I asked Corcept about the withdrawal and Corcept's CFO, Charles Robb responded. He said, Corcept withdrew Korlym for strategic reasons.
If approved in the EU, Korlym would be tied to the price of Mifepristone when used as an abortifacient — at about 1/4 the price Corcept charges in the USA for Cushing's.
If Corcept's new compound, 125134 were then later approved for Cushing's, 125134's price would be tied to the lower EU price for Korlym.
By withdrawing Korlym, if and when 125134 is approved for Cushing's, there will be less for the EU to use to limit the sales price of 125134.
By withdrawing Korlym, Corcept can fully enroll the trials for 125134 in the EU, without cannibalizing paying patients.
I didn't ask whether or not the withdrawl would affect their revenue guidance for the year but during the conference call, Corcept reaffirmed their earlier guidance $47–53M.
stocktrademan
10 년 전
$CORT recent news/filings
bullish
quick trade
## source: finance.yahoo.com
Mon, 06 Apr 2015 22:20:22 GMT ~ Nasdaq stocks posting largest percentage increases
[AP] - A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: Tonix Pharma rose 26.5 percent to $7.40. Trillium Therapeutic rose 16.4 percent to $11.12. Ebix Inc. rose 14.3 percent to ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************
Thu, 02 Apr 2015 20:07:15 GMT ~ CORCEPT THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure
read full: http://biz.yahoo.com/e/150402/cort8-k.html
*********************************************************
Thu, 02 Apr 2015 18:41:06 GMT ~ Corcept's Warrants Exercised, Invest in Korlym, Pipeline - Analyst Blog
read full: http://finance.yahoo.com/news/corcepts-warrants-exercised-invest-korlym-184106541.html
*********************************************************
Wed, 01 Apr 2015 21:20:21 GMT ~ Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym®
[at noodls] - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders ...
read full: http://www.noodls.com/view/BC11E4D0C0331300803839A1482C972268EBFA1A
*********************************************************
Wed, 01 Apr 2015 20:05:00 GMT ~ Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym(R)
[Marketwired] - Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating ...
read full: http://finance.yahoo.com/news/warrant-exercises-generate-17-2-200500765.html
*********************************************************
$CORT charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CORT company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CORT/company-info
Ticker: $CORT
OTC Market Place: Not Available
CIK code: 0001088856
Company name: Corcept Therapeutics, Inc.
Incorporated In: DE, USA
$CORT share structure
## source: otcmarkets.com
Market Value: $583,080,188 a/o Apr 06, 2015
Shares Outstanding: 101,405,250 a/o Mar 02, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$CORT extra dd links
Company name: Corcept Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CORT/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CORT/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CORT+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CORT+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CORT+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/news - http://finance.yahoo.com/q/h?s=CORT+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CORT/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CORT/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CORT/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CORT/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CORT/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CORT+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CORT
DTCC (dtcc.com): http://search2.dtcc.com/?q=Corcept+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Corcept+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Corcept+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CORT/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CORT
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CORT/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CORT/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CORT/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001088856&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CORT/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CORT/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CORT&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CORT
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CORT+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CORT+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CORT
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CORT
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CORT+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CORT/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CORT+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CORT.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CORT
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CORT/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CORT/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CORT/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CORT/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CORT
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CORT
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CORT:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CORT
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CORT
$CORT DD Notes ~ http://www.ddnotesmaker.com/CORT
Hot Features
프리미엄
브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Monksdream
8 월 전
CptChemtrail
4 년 전
ClayTrader
4 년 전
D E
6 년 전
FairviewInvestor
6 년 전
